Document:

Termination Agreement

 Exhibit 10.15 
 TERMINATION AGREEMENT 
 This Termination Agreement (the “Termination Agreement”) is dated
as of January 12, 2007, and is by and between Charlesbank Capital Partners, LLC, a Massachusetts limited liability company (“Charlesbank”), Animal Health International, Inc., a Delaware corporation formerly known as Steer Parent
Corporation and Walco International Holdings, Inc. (“Parent”), and Walco International, Inc., a Delaware corporation (the “Company”). 
 WITNESSETH 
 WHEREAS, Charlesbank, Parent and the Company are parties to that certain Corporate
Development and Administrative Services Agreement, dated as of June 30, 2005 (the “Agreement”); and 
 WHEREAS, Charlesbank,
Parent and the Company desire to have the Agreement terminate upon the initial public offering of the equity securities of Parent. 
 NOW
THEREFORE, in consideration of the premises and such other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged and agreed, the parties hereby agree as follows: 
  

	 	1.	Charlesbank, Parent and the Company hereby agree that immediately upon, and subject to, the consummation of the initial public offering of equity securities of Parent, on a firm
commitment underwritten basis pursuant to an effective registration statement under the Securities Act of 1933, as amended, the Agreement shall terminate and cease to have any force and effect. 

  

	 	2.	At or prior to the termination of the Agreement pursuant to this Termination Agreement, Parent and the Company shall reimburse Charlesbank for all fees and expenses incurred by
Charlesbank as provided in Section 2.1 of the Agreement. 

  

	 	3.	Except as provided herein, the Agreement shall remain unchanged and in full force and effect, and is hereby ratified and confirmed by the parties. 

  

	 	4.	This Termination Agreement shall be governed by and construed under the substantive laws (and not the laws of conflicts) of the State of Delaware. 

  

	 	5.	This Termination Agreement may be executed in one or more counterparts, each of which will be deemed to be an original copy of this Termination Agreement and all of which, when
taken together, will be deemed to constitute one and the same agreement. The exchange of copies of the Termination Agreement and of signature pages by facsimile transmission shall constitute effective execution and delivery of this Termination
Agreement as to the parties and may be used in lieu of the original Termination Agreement for all purposes. Signatures of the parties transmitted by facsimile shall be deemed to be their original signatures for all purposes.

 [SIGNATURE PAGE FOLLOWS] 

 IN WITNESS WHEREOF, the parties have executed this Termination Agreement as of the date first written
above. 
  

			
	CHARLESBANK CAPITAL PARTNERS, LLC
		
	By:	 	  
	Name:	 	
	Title:	 	
	
	ANIMAL HEALTH INTERNATIONAL, INC.
		
	By:	 	  
	Name:	 	
	Title:	 	
	
	WALCO INTERNATIONAL, INC.
		
	By:	 	  
	Name:	 	
	Its:Plan for Compensation of Non-Employee Directors

 Exhibit 10.28 
 ANIMAL HEALTH INTERNATIONAL, INC. 
 Compensation for Non-Employee Directors 
 Cash Fees 
 Retainer: 
 $30,000 annually payable in advance. 
 Meeting Fees:

 $2,500 per meeting, payable in arrears at the end of each calendar quarter for meetings attended during the quarter. Committee meetings
shall be counted separately (and meeting fees shall be paid for committee meetings), unless such meetings are held in conjunction with a meeting of the full Board of Directors (in which case a separate committee meeting fee shall not be paid).

 Conference Call Fees: 
 $500 per call
which constitutes a properly called special meeting of the Board or committee, payable in arrears at the end of each calendar quarter for conference calls attended during the quarter. 
 Chair Fees: 
 $10,000 annually for chairs of audit committee payable in advance. $5,000 annually for
chairs of governance or compensation committee payable in advance. 
 All cash fees (other than meeting fees and conference call fees) may be deferred at the
election of each Non-Employee Director pursuant to the Company’s Non-Employee Directors’ Deferred Compensation Program. All deferred fees are deemed invested in Deferred Stock Units payable in shares of common stock of the Company when the
Non-Employee Director ceases to serve on the Board. 
 Equity 
 Initial Equity Grant: 
 On the effective date of the Company’s initial public offering, each
Non-Employee Director serving on the Board on such date shall receive a grant of restricted Deferred Stock Units on such date. The number of units to be granted shall be equal to $40,000 divided by the “Price to the Public” (or equivalent)
set forth on the cover page of the final prospectus relating to the Company’s initial public offering. These units shall be fully vested on the anniversary date of grant, subject to service on the Board on such date. 

 Annual Equity Grant: 
 Each Non-Employee Director serving on the Board on the fifth business day after each annual meeting of stockholders, beginning with the 2007 annual meeting, shall receive a grant of restricted Deferred Stock Units on
such date. The number of units to be granted shall be equal to $40,000 divided by the reported closing price of the Company’s common stock on the Nasdaq Global Market on such date, or the preceding business date if there are no market
quotations on such date. These units shall be fully vested on the anniversary date of grant or the date of the next annual meeting of stockholders, whichever is earlier, subject to service on the Board on such date. 
 Equity Grant for a Non-Employee Director Whose Initial Election Is Other Than Pursuant to an Election at an Annual Meeting of Stockholders: 
 In the case of a Non-Employee Director whose initial election is other than pursuant to an election at an annual meeting of stockholders, he shall receive
an initial equity grant of restricted Deferred Stock Units on the date he first joins the Board. The number of units to be granted shall be equal to $40,000 (pro-rated for days of service on the Board until the date of the next annual equity grant)
divided by the reported closing price of the Company’s common stock on the Nasdaq Global Market on such date, or the preceding business date if there are no market quotations on such date. These units shall be fully vested on the anniversary
date of grant, subject to service on the Board on such date. 
  

 2Non-Employee Directors" Deferred Compensation Program

 Exhibit 10.29 
 ANIMAL HEALTH INTERNATIONAL, INC. 
 NON-EMPLOYEE DIRECTORS’ 
 DEFERRED COMPENSATION PROGRAM 
  

	I.	INTRODUCTION 

 The Animal Health International, Inc.
Non-Employee Directors’ Deferred Compensation Program (the “Program”), effective January 8, 2007, is established pursuant to the Animal Health International, Inc. 2007 Stock Option and Incentive Plan (the “Plan”) and
permits a Director who is not an employee of the Company (a “Non-Employee Director”) to defer receipt of certain cash compensation payable to him by the Company. 
  

	II.	ADMINISTRATION 

 The Program shall be administered
by the Compensation Committee of the Board of Directors of the Company (the “Committee”). The Committee shall have complete discretion and authority with respect to the Program and its application, except as expressly limited by the
Program. 
  

	III.	ELIGIBILITY 

 All Non-Employee Directors are
eligible to participate in the Program. 
  

	IV.	DEFERRAL OF CASH FEES 

 A Non-Employee Director may
elect in advance to defer the receipt of certain cash fees from the Company, including retainer payments and fees payable for Board or committee chairmanships (the “Eligible Payments”). Meeting fees and conference call fees shall be paid
in cash and may not be deferred under the Program. To make an election to defer the Eligible Payments, the Non-Employee Director must execute and deliver to the Committee an election form specifying the percentage of his Eligible Payments he wishes
to defer. Except with respect 

 
to a newly elected or appointed Non-Employee Director or in connection with the establishment of this Program, any election under this paragraph shall apply
only to Eligible Payments that are earned with respect to services to be performed beginning on or after the start of the next calendar year after such receipt and acceptance. A Non-Employee Director who is serving as a director on the Effective
Date may, within 30 days of the Effective Date, file a deferral election which shall apply to Eligible Payments that are earned with respect to services performed subsequent to the election. A newly elected or appointed Non-Employee Director, may,
within 30 days of becoming a Non-Employee Director, file a deferral election which shall apply only to Eligible Payments that are earned with respect to services to be performed subsequent to the election. An election shall remain in effect from
year to year, until a new election becomes effective with respect to Eligible Payments payable in the next calendar year. A Non-Employee Director may revoke his deferral election with respect to Eligible Payments that are payable in the calendar
year beginning after receipt and acceptance by the Company of his written revocation. 
 A. Deferred Account. As of the date of
payment of the Eligible Payments, a Non-Employee Director’s deferred account (“Account”) shall be credited with a number of whole and fractional stock units determined by dividing his deferred Eligible Payments by the fair market
value of a share of common stock, par value $0.01 per share, of the Company (“Stock”). For purposes of this Program, “fair market value” of a share of Stock on any given date shall mean the last reported sale price at which Stock
is traded on such date, or if no Stock is traded on such date, the most recent date on which Stock was traded on the NASDAQ Global Market, or if applicable, any other national stock exchange on which Stock is traded; provided, however, that if the
date for which fair market value is being determined is the first day when 

  

 2 

 
trading prices for the stock are reported on NASDAQ Global Market or a national securities exchange, the fair market value shall be the “Price to the
Public” (or equivalent) set forth on the cover page for the final prospectus relating to the Company’s Initial Public Offering. 
 B. Dividend Equivalent Amounts. Whenever dividends (other than dividends payable only in shares of Stock) are paid with respect to Stock, each Account shall be credited with a number of whole and fractional stock units determined by
multiplying the dividend value per share by the stock unit balance of the Account on the record date and dividing the result by the fair market value of a share of Stock on the dividend payment date. 
 C. Designation of Beneficiary. A Non-Employee Director may designate one or more beneficiaries to receive payments from his Account in the event
of his death. A designation of beneficiary shall apply to a specified percentage of a Non-Employee Director’s entire interest in his Account. Such designation, or any change therein, must be in writing and shall be effective upon receipt by the
Company. If there is no effective designation of beneficiary, or if no beneficiary survives the Non-Employee Director, the estate of the Non-Employee Director shall be deemed to be the beneficiary. All payments to a beneficiary or estate shall be
made in a lump sum in shares of Stock, with any fractional share paid in cash. 
 D. Payment. All stock units credited to a
Non-Employee Director’s Account shall be paid in shares of Stock to the Non-Employee Director, or his designated beneficiary (or beneficiaries) or estate, in a lump sum; provided, however, that fractional shares shall be paid in cash. Such
payment shall be made as soon as practicable after the Non-Employee Director ceases to be a member of the Board of Directors of the Company. Notwithstanding the foregoing, in the event of a Sale Event (as defined in Section 3(c) of the Plan),
all Accounts under the Program shall become immediately payable in a lump sum. 
  

 3 

	V.	ADJUSTMENTS 

 In the event of a stock dividend,
stock split or similar change in capitalization affecting the Stock, the Committee shall make appropriate adjustments in the number of stock units credited to Non-Employee Directors’ Accounts. 
  

	VI.	AMENDMENT OR TERMINATION OF PROGRAM 

 The Company
reserves the right to amend or terminate the Program at any time, by action of its Board of Directors, provided that no such action shall adversely affect a Non-Employee Director’s right to receive compensation earned before the date of such
action or his rights under the Program with respect to amounts credited to his Account before the date of such action. In no event shall the distribution of Accounts to Non-Employee Directors be accelerated by virtue of any amendment or termination
of the Program, except to the extent permitted by Section 409A of the Internal Revenue Code of 1986. 
  

	VII.	MISCELLANEOUS PROVISIONS 

 A. Notices. Any
notice required or permitted to be given by the Company or the Committee pursuant to the Program shall be deemed given when personally delivered or deposited in the United States mail, registered or certified, postage prepaid, addressed to the
Non-Employee Director at the last address shown for the Non-Employee Director on the records of the Company. 
 B. Nontransferability of
Rights. During a Non-Employee Director’s lifetime, any payment under the Program shall be made only to him. No sum or other interest under the Program shall be subject in any manner to anticipation, alienation, sale, transfer, assignment,
pledge, encumbrance or charge, and any attempt by a Non-Employee Director or any beneficiary under the Program to do so shall be void. No interest under the Program shall in any manner be 

  

 4 

 
liable for or subject to the debts, contracts, liabilities, engagements or torts of a Non-Employee Director or beneficiary entitled thereto. 
 C. Company’s Obligations to Be Unfunded and Unsecured. The Accounts maintained under the Program shall at all times be entirely unfunded, and
no provision shall at any time be made with respect to segregating assets of the Company (including Stock) for payment of any amounts hereunder. No Non-Employee Director or other person shall have any interest in any particular assets of the Company
(including Stock) by reason of the right to receive payment under the Program, and any Non-Employee Director or other person shall have only the rights of a general unsecured creditor of the Company with respect to any rights under the Program.

 D. Governing Law. The terms of the Program shall be governed, construed, administered and regulated in accordance with the laws of
the State of Delaware. In the event any provision of this Program shall be determined to be illegal or invalid for any reason, the other provisions shall continue in full force and effect as if such illegal or invalid provision had never been
included herein. 
 E. Effective Date of Program. The Program shall become effective upon the effective date of the Company’s
initial public offering. 
  

 5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00115-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00115-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00115-of-00352.parquet"}]]